Sort
34,240 grants matching “atherosclerosis”
A Revolutionary Therapy for Atherosclerosis: Liquid Cast Arterial Stents
$494,105Guillermo A Ameer · Northwestern University At Chicago · RC1 · FY2010 · HL
Post-DPP Follow-up Study
$493,951University Of Colorado Denver · U01 · FY2003 · DK
Apolipoprotein Genes and Atherogenesis in Animals
$493,914Nobuyo Maeda · Univ Of North Carolina Chapel Hill · R01 · FY2009 · HL
Project 3: Lipolysis regulation and diabetes-impaired regression
$493,885Ira Jay Goldberg · University Of Washington · P01 · FY2022 · HL
Diabetes Prevention Program Outcomes Study - Phase 2
$493,878David Grayson Marrero · Indiana University Indianapolis · U01 · FY2011 · DK
Project 3: Lipolysis regulation and diabetes-impaired regression
$493,774Ira Jay Goldberg · University Of Washington · P01 · FY2021 · HL
CVD GENETIC PREDISPOSITIONS AND GENOMIC SIGNATURES
$493,656Winston C Patterson · Univ Of North Carolina Chapel Hill · P50 · FY2014 · HL
RAGE, Diabetes and Myocardial Infarction
$493,600Ravichandran Ramasamy · New York University School Of Medicine · R01 · FY2011 · HL
ROS, Inflammation, and Cardioprotection in Type 2 Diabetes
$493,566Rakesh C. Kukreja · Virginia Commonwealth University · R01 · FY2014 · HL
Early Imaging Detection of CV Injury after Cancer
$493,241William Gregory Hundley · Wake Forest University Health Sciences · R01 · FY2012 · CA
Activation of Xenogeneic Endothelium to Resist Injury
$493,228Agustin P Dalmasso · University Of Minnesota · R01 · FY2010 · HL
DPPOS Follow-up
$493,213Vanita Aroda · Medstar Health Research Institute · U01 · FY2015 · DK
"MerTK Cleavage and Signaling in Atherosclerosis"
$493,137Ira A Tabas · Columbia University Health Sciences · R01 · FY2018 · HL
"MerTK Cleavage and Signaling in Atherosclerosis"
$493,137Ira A Tabas · Columbia University Health Sciences · R01 · FY2017 · HL
Copper transport protein and inflammatory angiogenesis
$493,008Tohru Fukai · University Of Illinois At Chicago · R01 · FY2016 · HL
GENETIC ANALYSIS OF CVD RISK FACTORS
$493,007Laura A. Almasy · Texas Biomedical Research Institute · P01 · FY2010 · HL
GENETIC ANALYSIS OF CVD RISK FACTORS
$493,007Laura A. Almasy · Texas Biomedical Research Institute · P01 · FY2011 · HL
GENETIC ANALYSIS OF CVD RISK FACTORS
$493,004Laura A. Almasy · Texas Biomedical Research Institute · P01 · FY2012 · HL
Phage-based targeted imaging probes and their application to vascular diseases
$492,966Trevor Douglas · Trustees Of Indiana University · R01 · FY2013 · EB
Role of PUFA-Gene Interactions in Health Disparities
$492,933Floyd H Chilton · University Of Arizona · R01 · FY2018 · AT
Biomarker Matrix for Genotoxicity Mode of Action
$492,904Stephen D Dertinger · Litron Laboratories, Ltd. · R44 · FY2015 · ES
Growth Hormone and Rosiglitazone for Visceral Adoposity
$492,881Weill Medical College Of Cornell Univ · R01 · FY2005 · DK
Genetic Risk Stratification to Identify Individuals for Early Statin Therapy
$492,835Marc S Sabatine · Brigham And Women'S Hospital · RC1 · FY2010 · HL
Genetics and Environment in Adult Respiratory, Allergic and Cardiac disease
$492,801Stephanie London · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES
Alpha-Adrenoceptors in Vascular Wall Growth
$492,790James E Faber · Univ Of North Carolina Chapel Hill · R01 · FY2008 · HL